Bettina Mesplès

1.1k total citations
25 papers, 832 citations indexed

About

Bettina Mesplès is a scholar working on Pediatrics, Perinatology and Child Health, Immunology and Epidemiology. According to data from OpenAlex, Bettina Mesplès has authored 25 papers receiving a total of 832 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pediatrics, Perinatology and Child Health, 6 papers in Immunology and 5 papers in Epidemiology. Recurrent topics in Bettina Mesplès's work include Neonatal and fetal brain pathology (6 papers), Neuroscience and Neuropharmacology Research (3 papers) and Adenosine and Purinergic Signaling (3 papers). Bettina Mesplès is often cited by papers focused on Neonatal and fetal brain pathology (6 papers), Neuroscience and Neuropharmacology Research (3 papers) and Adenosine and Purinergic Signaling (3 papers). Bettina Mesplès collaborates with scholars based in France, United States and Belgium. Bettina Mesplès's co-authors include Pierre Gressèns, R Fontaine, Philippe Evrard, Isabelle Husson, Christine Bonnier, Jòseph Vamecq, Pierre Bac, Frank Plaisant, Franck Plaisant and Vincent Lelièvre and has published in prestigious journals such as PEDIATRICS, Annals of Neurology and Neuroscience.

In The Last Decade

Bettina Mesplès

25 papers receiving 819 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bettina Mesplès France 16 425 162 115 112 112 25 832
Veena G. Supramaniam United Kingdom 15 599 1.4× 305 1.9× 136 1.2× 99 0.9× 93 0.8× 22 843
Pernilla Svedin Sweden 17 650 1.5× 303 1.9× 253 2.2× 125 1.1× 286 2.6× 36 1.2k
Jessie R. Maxwell United States 15 432 1.0× 146 0.9× 57 0.5× 126 1.1× 49 0.4× 41 614
Cacha Peeters‐Scholte Netherlands 19 514 1.2× 203 1.3× 199 1.7× 88 0.8× 61 0.5× 51 891
Michael J Cole Australia 14 279 0.7× 78 0.5× 85 0.7× 43 0.4× 309 2.8× 16 898
A. Keyser Netherlands 20 455 1.1× 106 0.7× 315 2.7× 137 1.2× 67 0.6× 59 1.5k
Ali S. Çalıkoğlu United States 19 222 0.5× 78 0.5× 380 3.3× 156 1.4× 30 0.3× 44 1.6k
Amy E. Sutherland Australia 22 787 1.9× 610 3.8× 89 0.8× 75 0.7× 60 0.5× 54 1.1k
Yiran Xu China 16 126 0.3× 99 0.6× 304 2.6× 79 0.7× 82 0.7× 66 724
S Harel Israel 15 308 0.7× 143 0.9× 290 2.5× 49 0.4× 24 0.2× 34 914

Countries citing papers authored by Bettina Mesplès

Since Specialization
Citations

This map shows the geographic impact of Bettina Mesplès's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bettina Mesplès with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bettina Mesplès more than expected).

Fields of papers citing papers by Bettina Mesplès

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bettina Mesplès. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bettina Mesplès. The network helps show where Bettina Mesplès may publish in the future.

Co-authorship network of co-authors of Bettina Mesplès

This figure shows the co-authorship network connecting the top 25 collaborators of Bettina Mesplès. A scholar is included among the top collaborators of Bettina Mesplès based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bettina Mesplès. Bettina Mesplès is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mesplès, Bettina, et al.. (2024). Safety of Obinutuzumab in Children With Autoimmune Encephalitis and Early B-Cell Repopulation on Rituximab. Pediatric Neurology. 156. 79–84. 1 indexed citations
2.
Orbach, Daniel, Thomas Hanslik, Benoît Brethon, et al.. (2022). Varicella post-exposure management for pediatric oncology patients. Bulletin du Cancer. 109(3). 287–295. 2 indexed citations
3.
Barnérias, Christine, Marie Hully, Cyril Gitiaux, et al.. (2022). Indications and Safety of Rituximab in Pediatric Neurology: A 10-Year Retrospective Study. Pediatric Neurology. 137. 41–48. 3 indexed citations
4.
Mosseri, Véronique, Bettina Mesplès, B. Pellegrino, et al.. (2016). Parcours prédiagnostique des enfants et adolescents atteints de tumeurs solides. Bulletin du Cancer. 104(2). 128–138. 7 indexed citations
5.
Baulny, Hélène Ogier de, Renata Kozyraki, Sandrine Passemard, et al.. (2012). How can cobalamin injections be spaced in long-term therapy for inborn errors of vitamin B12 absorption?. Molecular Genetics and Metabolism. 107(1-2). 66–71. 15 indexed citations
6.
Angoulvant, François, K. Chadelat, Agathe de Lauzanne, et al.. (2012). Contage tuberculeux néonatal en maternité : dépistage et évolution d’une cohorte de nourrissons exposés. Archives de Pédiatrie. 19(4). 396–403. 5 indexed citations
7.
Odièvre, Marie‐Hélène, Névéna Danékova, Bettina Mesplès, et al.. (2011). Unsuspected glucose-6-phosphate dehydrogenase deficiency presenting as symptomatic methemoglobinemia with severe hemolysis after fava bean ingestion in a 6-year-old boy. International Journal of Hematology. 93(5). 664–666. 15 indexed citations
8.
Odièvre, Marie‐Hélène, Névéna Danékova, Claude Picard, et al.. (2011). Pneumopathie hypoxémiante à adénovirus de type 7 chez un nourrisson sans déficit immunitaire. Archives de Pédiatrie. 18(7). 772–777. 8 indexed citations
9.
Fréneaux, Paul, Gudrun Schleiermacher, Hervé J. Brisse, et al.. (2011). Risk‐adapted therapy for infantile myofibromatosis in children. Pediatric Blood & Cancer. 59(1). 115–120. 30 indexed citations
10.
Fontaine, R, Olivier Cases, Vincent Lelièvre, et al.. (2008). IL-9/IL-9 receptor signaling selectively protects cortical neurons against developmental apoptosis. Cell Death and Differentiation. 15(10). 1542–1552. 73 indexed citations
11.
Rosen, Glenn D., Bettina Mesplès, Marleen Elisabeth Hendriks, & Albert M. Galaburda. (2006). Histometric changes and cell death in the thalamus after neonatal neocortical injury in the rat. Neuroscience. 141(2). 875–888. 18 indexed citations
12.
Mesplès, Bettina, Franck Plaisant, R Fontaine, & Pierre Gressèns. (2005). Pathophysiology of neonatal brain lesions: Lessons from animal models of excitotoxicity. Acta Paediatrica. 94(2). 185–190. 44 indexed citations
13.
Bonnier, Christine, Bettina Mesplès, & Pierre Gressèns. (2004). Animal models of shaken baby syndrome: revisiting the pathophysiology of this devastating injury. Pediatric Rehabilitation. 7(3). 165–171. 25 indexed citations
14.
Husson, Isabelle, Bettina Mesplès, Fadia Medja, et al.. (2004). Methylphenidate and MK-801, an N-methyl-d-aspartate receptor antagonist: shared biological properties. Neuroscience. 125(1). 163–170. 27 indexed citations
15.
Mesplès, Bettina, R Fontaine, Vincent Lelièvre, Jean-Marie Launay, & Pierre Gressèns. (2004). Neuronal TGF-β1 mediates IL-9/mast cell interaction and exacerbates excitotoxicity in newborn mice. Neurobiology of Disease. 18(1). 193–205. 43 indexed citations
16.
Mesplès, Bettina, Frank Plaisant, & Pierre Gressèns. (2003). Effects of interleukin-10 on neonatal excitotoxic brain lesions in mice. Developmental Brain Research. 141(1-2). 25–32. 70 indexed citations
17.
Bonnier, Christine, et al.. (2002). Delayed White Matter Injury in a Murine Model of Shaken Baby Syndrome. Brain Pathology. 12(3). 320–328. 50 indexed citations
18.
Husson, Isabelle, Bettina Mesplès, Pierre Bac, et al.. (2001). Melatoninergic neuroprotection of the murine periventricular white matter against neonatal excitotoxic challenge. Annals of Neurology. 51(1). 82–92. 159 indexed citations
19.
Patkaï, Juliana, Bettina Mesplès, Marie‐Aliette Dommergues, et al.. (2001). Deleterious Effects of IL-9–Activated Mast Cells and Neuroprotection by Antihistamine Drugs in the Developing Mouse Brain. Pediatric Research. 50(2). 222–230. 52 indexed citations
20.
Gressèns, Pierre, Bettina Mesplès, Nadia Sahir, Stéphane Marret, & Augusto Sola. (2001). Environmental factors and disturbances of brain development. Seminars in Neonatology. 6(2). 185–194. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Veena G. Supramaniam Breakdown of academic impact, for papers by Pernilla Svedin Breakdown of academic impact, for papers by Jessie R. Maxwell Breakdown of academic impact, for papers by Cacha Peeters‐Scholte Breakdown of academic impact, for papers by Michael J Cole Breakdown of academic impact, for papers by A. Keyser Breakdown of academic impact, for papers by Ali S. Çalıkoğlu Breakdown of academic impact, for papers by Amy E. Sutherland Breakdown of academic impact, for papers by Yiran Xu Breakdown of academic impact, for papers by S Harel
Rankless by CCL
2026